Developer of cardiovascular therapeutics intended to treat cardiovascular diseases. The company's therapeutics offer advanced novel mechanisms to develop new treatments for heart diseases, causing mor...

Biotechnology
Healthcare
Burlington, MA, United States
Founded 2017
50 employees
Website
Valuation
$760M
Market implied
Share Price
N/A
Total Raised
$621.8M
Last Round
Later Stage VC (Series B)
Jul 2024

Get the full picture

Create a free account to unlock Cardurion's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required